Trial Profile
Efficacy of Flunisolide HFA (AEROSPAN) in Children 4 to 11 Years of Age
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jul 2016
Price :
$35
*
At a glance
- Drugs Flunisolide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 18 May 2016 Results assessing HPA-axis functioning from two 12-week trials presented at the 112th International Conference of the American Thoracic Society
- 07 Aug 2015 New trial record